East Hanover, NJ, United States of America

Jacqueline Kinyamu-Akunda

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacqueline Kinyamu-Akunda. Retrieved from https://idiyas.com/inventor/jacqueline-kinyamu-akunda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jacqueline Kinyamu-Akunda

Introduction

Jacqueline Kinyamu-Akunda is a notable inventor based in East Hanover, NJ (US). She has made significant strides in the field of pharmaceuticals, particularly in cancer treatment. Her work exemplifies the intersection of innovation and healthcare, showcasing her commitment to improving patient outcomes.

Latest Patents

Jacqueline holds a patent for her invention titled "Combinations of FGFR4 inhibitors and bile acid sequestrants." This pharmaceutical combination aims to enhance cancer treatment by utilizing an FGFR4 inhibitor alongside a bile acid sequestrant. The invention not only focuses on the efficacy of cancer therapy but also addresses the side effects associated with FGFR4 inhibition therapy.

Career Highlights

Jacqueline is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to contribute to groundbreaking research and development in the pharmaceutical industry. With her expertise, she plays a vital role in advancing innovative solutions for complex health challenges.

Collaborations

Jacqueline collaborates with esteemed colleagues, including Robin Alec Fairhurst and Diana Graus Porta. These partnerships enhance her research efforts and foster a collaborative environment that drives innovation in the pharmaceutical sector.

Conclusion

Jacqueline Kinyamu-Akunda's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her innovative spirit and dedication to improving healthcare. Her patent and work at Novartis AG reflect her significant impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…